A historic shift in our drug policy has happened, as the regulators allow the use of psilocybin hallucinogens for therapeutic treatment. Before this, these substances were severely restricted, but a growing body of research suggests they potentially offer aid for mental health issues like anxiety. The new policy represents a substantial step toward